02.24.23 -- What Role Does RWD Play In Walgreens, CVS Clinical Trials?

Walgreens’ head of decentralized clinical trials, John Campbell, and CVS’s health senior VP of clinical trial services, Tony Clapsis, talk about how real-world evidence (RWD) is being used in their clinical trials.

Master classical methods for automated image interpretation and contrast them with the AI techniques that have largely replaced them.

While biomarkers have improved trial efficiency in some cases, delve into why patient-centered clinical outcome assessments remain essential.

Explore a few options that leaders should consider when determining how best to leverage and position data science expertise to support clinical data operations.

The data management profession has become increasingly complex over the past few decades, and today’s clinical data manager has created more clearly defined roles within their organization.

At OpenClinica, our goal is to provide you with ‘Better Data, Faster.’ Hear firsthand how our senior solutions consultant, Galen Tran, has experienced building initial studies more than a week faster with OpenClinica’s solution suite, compared to other EDCs.

Decisions taken within Pro-ficiency's simulations are reflected in easy-to-interpret behavioral performance reports, informing study teams on site performance before mistakes turn into deviations.

IQVIA Feasibility brings together survey data, confidential disclosure agreements (CDAs), and site intelligence data, enabling sponsors to efficiently collect vital information while improving the site experience.

With the implementation of real-time remote monitoring technology, pharma companies will be able to do more remote studies that require clinical trial patients to visit sites less frequently. This will remove the burden on patients and improve patient recruitment and retention. This article focuses on the patient medication adherence market.

Alex Watt, global head for biotech integrated laboratory solutions, and Alan Wookey, global head of companion diagnostics, discuss how to manage both scientific and operational risk in clinical trials for biotech companies.

Increased industry costs are driving reflection toward current practices in order to determine where efforts can be decreased in order to save costs. Learn how risk-based monitoring has drastically reduced the cost of clinical monitoring.